Kul Aggarwal, MD
Interventional Cardiology · Columbia, MONPI 1720038300
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,560 of the $4,092 with a category attached, or 62.6%. 13 manufacturers reported payments, led by Abbott at 54.9% of the total. Reporting peaked in 2019 at $2,734 and has fallen 93.8% since, to $169 in 2025. That places this record below the midpoint for interventional cardiology clinicians in MO, where the typical reported total is $10,448.
Across 62 payments — averaging $66.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$224
- Boston Scientific$183
- Biotronik Inc.$134
- Siemens Medical Solutions USA, Inc.$37
- plus $186 from 7 others
Across 15 payments — averaging $34,627 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$457K
- AstraZeneca$24K
- Amgen$22K
- Merck$17K
What the payments were for
- Travel & lodging$1,53237%
- Food & beverage$2,56063%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 25 | $2,246 |
| Medtronic(2 entities) | 13 | $1,081 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $224 |
| Boston Scientific | 6 | $183 |
| Biotronik Inc. | 1 | $134 |
| Siemens Medical Solutions USA, Inc. | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Novartis | 2 | $34 |
| Pfizer | 2 | $28 |
| Livanova USA, Inc. | 1 | $24 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $23 |
| Avinger Inc. | 1 | $22 |
| Amgen | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,092 in reported general payments places this provider in the 25th percentile of 182 interventional cardiology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Columbia
- Taishi HiraiColumbia$150K
- Arun KumarColumbia$17K
- Michael BrownColumbia$17K
- Joshua StolkerWashington$1.2M
- John LasalaSaint Louis$936K
- Harvey SerotaSaint Louis$752K
- Jasvindar SinghSaint Louis$696K
- Gerald MancusoKansas City$402K
- James GranthamKansas City$357K
- Matthew BunteKansas City$242K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.